Bavarian Nordic and its partners conduct clinical studies of its vaccine candidates to evaluate their safety and efficacy.
Clinical studies that are actively enrolling patients or are planned are detailed below.
Ongoing or planned trials
|Phase 1/2 Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, ALT-803 and Epacadostat (QuEST1)
Read more: NCT03493945